Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8721 | 1155 | 43.5 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CIITA | Author keyword | 103 | 68% | 8% | 91 |
2 | BARE LYMPHOCYTE SYNDROME | Author keyword | 44 | 85% | 2% | 23 |
3 | CLASS II TRANSACTIVATOR | Author keyword | 34 | 69% | 3% | 29 |
4 | MHC CLASS II DEFICIENCY | Author keyword | 30 | 84% | 1% | 16 |
5 | CELLULAR MOL BIOL PHYSIOL | Address | 13 | 80% | 1% | 8 |
6 | RFX5 | Author keyword | 13 | 71% | 1% | 10 |
7 | REGULATORY FACTOR X | Author keyword | 12 | 86% | 1% | 6 |
8 | LOUIS JEANTET MOL GENET | Address | 9 | 83% | 0% | 5 |
9 | CLASS II TRANS ACTIVATOR | Author keyword | 6 | 80% | 0% | 4 |
10 | MHC II DEFICIENCY | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CIITA | 103 | 68% | 8% | 91 | Search CIITA | Search CIITA |
2 | BARE LYMPHOCYTE SYNDROME | 44 | 85% | 2% | 23 | Search BARE+LYMPHOCYTE+SYNDROME | Search BARE+LYMPHOCYTE+SYNDROME |
3 | CLASS II TRANSACTIVATOR | 34 | 69% | 3% | 29 | Search CLASS+II+TRANSACTIVATOR | Search CLASS+II+TRANSACTIVATOR |
4 | MHC CLASS II DEFICIENCY | 30 | 84% | 1% | 16 | Search MHC+CLASS+II+DEFICIENCY | Search MHC+CLASS+II+DEFICIENCY |
5 | RFX5 | 13 | 71% | 1% | 10 | Search RFX5 | Search RFX5 |
6 | REGULATORY FACTOR X | 12 | 86% | 1% | 6 | Search REGULATORY+FACTOR+X | Search REGULATORY+FACTOR+X |
7 | CLASS II TRANS ACTIVATOR | 6 | 80% | 0% | 4 | Search CLASS+II+TRANS+ACTIVATOR | Search CLASS+II+TRANS+ACTIVATOR |
8 | MHC II DEFICIENCY | 6 | 100% | 0% | 4 | Search MHC+II+DEFICIENCY | Search MHC+II+DEFICIENCY |
9 | MHC2TA | 4 | 50% | 1% | 6 | Search MHC2TA | Search MHC2TA |
10 | RFXANK | 4 | 75% | 0% | 3 | Search RFXANK | Search RFXANK |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BARE LYMPHOCYTE SYNDROME | 357 | 69% | 27% | 308 |
2 | CIITA | 132 | 68% | 10% | 116 |
3 | X BOX REGION | 98 | 100% | 3% | 29 |
4 | TRANSACTIVATOR CIITA | 97 | 64% | 8% | 94 |
5 | X BOX BINDING | 72 | 100% | 2% | 23 |
6 | DR ALPHA GENE | 50 | 81% | 3% | 30 |
7 | CIITA INTERACTS | 48 | 100% | 1% | 17 |
8 | X BOX | 44 | 85% | 2% | 23 |
9 | HLA DRA GENE | 42 | 78% | 2% | 28 |
10 | CLASS II TRANSACTIVATOR | 30 | 31% | 7% | 83 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The bare lymphocyte syndrome and the regulation of MHC expression | 2001 | 306 | 168 | 83% |
CIITA and its dual roles in MAC gene transcription | 2013 | 13 | 49 | 71% |
Genetic control of MHC class II expression | 2002 | 205 | 101 | 69% |
Regulation of MHC class II genes: Lessons from a disease | 1996 | 338 | 127 | 70% |
Epigenetic regulation of MHC-II and CIITA genes | 2006 | 86 | 63 | 81% |
Specificity and expression of CIITA, the master regulator of MHC class II genes | 2004 | 136 | 111 | 69% |
Regulation of MHC class II gene expression by the class II transactivator | 2005 | 137 | 133 | 69% |
SEQUENCES AND FACTORS - A GUIDE TO MHC CLASS-II TRANSCRIPTION | 1992 | 517 | 208 | 55% |
Transcriptional regulation of the MHC class II antigen presentation pathway | 2003 | 91 | 46 | 85% |
Transcriptional regulation of antigen presentation | 2004 | 88 | 51 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELLULAR MOL BIOL PHYSIOL | 13 | 80% | 0.7% | 8 |
2 | LOUIS JEANTET MOL GENET | 9 | 83% | 0.4% | 5 |
3 | UNIT CELLULAR MOL GENET | 6 | 100% | 0.3% | 4 |
4 | HANS SPEMANN S | 4 | 46% | 0.5% | 6 |
5 | SERV CATTEDRA IMMUNOL | 3 | 100% | 0.3% | 3 |
6 | IMMUNOL TRANSPLANT UNIT | 1 | 31% | 0.3% | 4 |
7 | L JEANTET MOL GENET | 1 | 100% | 0.2% | 2 |
8 | UNITE IMMUNOGENET HUMAINE | 1 | 19% | 0.5% | 6 |
9 | U396 | 1 | 11% | 0.8% | 9 |
10 | ANALYT MICROSCOPY CORE | 1 | 27% | 0.3% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000110625 | MURINE MAB//CYTOTOXICITY IMMUNOLOGICAL//DR2 HAPLOTYPES |
2 | 0.0000108990 | NF Y//NF YB//CCAAT BOX |
3 | 0.0000078429 | INVARIANT CHAIN//HLA DM//ANTIGEN PROCESSING |
4 | 0.0000077687 | ANTIGEN PROCESSING MACHINERY//BIOQUIM BIOL MOL INMUNOL 3//HLA CLASS I |
5 | 0.0000074284 | CELL BIOL IMMUNOL SECT//HUMAN NEURAL DEVELOPMENT//LEWIS THOMAS S 123 |
6 | 0.0000074093 | U396//HU1D10//UNITE 396 |
7 | 0.0000056133 | HLA A2 GENE//NONCLASSICAL MHC I//DRUG DESIGN DEV GRP |
8 | 0.0000055311 | IRF 1//IRF 2//INTERFERON REGULATORY FACTOR 1 |
9 | 0.0000052802 | RIZ1//PRDM//RIZ |
10 | 0.0000050869 | HUMAN INTERFERON GAMMA//INTERFERON GAMMA RECEPTOR//HIFN GAMMA |